LCGLA
CVS icon

LYNX CAPITAL GROUP LTD /ADV’s CVS Health CVS Stock Holding History

LYNX CAPITAL GROUP LTD /ADV’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$1.96M Buy
+24,799
New +$1.76M 1.43% 37

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

LYNX CAPITAL GROUP LTD /ADV's CVS Position: Q4 2023 in Review

LYNX CAPITAL GROUP LTD /ADV opened a new position in CVS Health (CVS) in Q4 2023: 24,799 shares worth $1.96M. The stake represents 1.43% of the portfolio and ranks #37 among its holdings.

2,260 funds tracked by Wall St. Rank hold CVS as of Q4 2023.

  • LYNX CAPITAL GROUP LTD /ADV held 24,799 shares of CVS Health worth $1.96M as of Q4 2023.
  • CVS Health was a new LYNX CAPITAL GROUP LTD /ADV position in Q4 2023.
  • CVS Health made up 1.43% of LYNX CAPITAL GROUP LTD /ADV's portfolio in Q4 2023, its #37 holding.
  • 2,260 funds tracked by Wall St. Rank held CVS Health as of Q4 2023.

Based on LYNX CAPITAL GROUP LTD /ADV's 13F filing for Q4 2023, filed 7 Aug 2026.